• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香芹酚衍生的1,2,3-三唑杂化物:合成、计算分析以及对表皮生长因子受体、BRAF V600E和微管蛋白酶的靶向抑制

Carvacrol-Derived 1,2,3-Triazole Hybrids: Synthesis, Computational Insights, and Targeted Inhibition of EGFR, BRAF V600E, and Tubulin Enzymes.

作者信息

Enneiymy Mohamed, El Aissouq Abdellah

机构信息

Laboratory of Organic and Physical Chemistry, Applied Bioorganic Chemistry Team, Faculty of Sciences, Ibnou Zohr University, Agadir, Morocco.

Laboratory of Processes, Materials, and Environment (LPME), Faculty of Science and Technology, Sidi Mohamed Ben Abdellah University, Fez, Morocco.

出版信息

J Fluoresc. 2025 Mar 18. doi: 10.1007/s10895-025-04232-y.

DOI:10.1007/s10895-025-04232-y
PMID:40100316
Abstract

This study explores the design and synthesis of innovative triazole-carvacrol hybrid molecules via copper-catalyzed 1,3-dipolar cycloaddition reactions. Leveraging advanced computational drug design tools, the ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiles of these compounds will be meticulously evaluated. Furthermore, molecular docking simulations will unravel the binding interactions and mechanisms with critical cancer therapy targets, including EGFR (PDB ID: 3POZ), BRAF V600E (PDB ID: 1UWJ), and Tubulin (PDB ID: 1SA0). By integrating cutting-edge synthesis and computational techniques, this work aims to uncover potent candidates with significant therapeutic potential in cancer treatment.

摘要

本研究通过铜催化的1,3-偶极环加成反应探索创新的三唑-香芹酚杂化分子的设计与合成。利用先进的计算药物设计工具,将对这些化合物的ADMET(吸收、分布、代谢、排泄和毒性)概况进行细致评估。此外,分子对接模拟将揭示与关键癌症治疗靶点(包括表皮生长因子受体(PDB ID:3POZ)、BRAF V600E(PDB ID:1UWJ)和微管蛋白(PDB ID:1SA0))的结合相互作用及机制。通过整合前沿的合成和计算技术,这项工作旨在发现具有显著癌症治疗潜力的强效候选物。

相似文献

1
Carvacrol-Derived 1,2,3-Triazole Hybrids: Synthesis, Computational Insights, and Targeted Inhibition of EGFR, BRAF V600E, and Tubulin Enzymes.香芹酚衍生的1,2,3-三唑杂化物:合成、计算分析以及对表皮生长因子受体、BRAF V600E和微管蛋白酶的靶向抑制
J Fluoresc. 2025 Mar 18. doi: 10.1007/s10895-025-04232-y.
2
Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF: Design, Synthesis, and Antiproliferative Activity.喹唑啉-4-酮/3-氰基吡啶-2-酮杂化物作为表皮生长因子受体(EGFR)和B-Raf原癌基因(BRAF)的双重抑制剂:设计、合成及抗增殖活性
Pharmaceuticals (Basel). 2023 Oct 26;16(11):1522. doi: 10.3390/ph16111522.
3
design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer.设计、基于药效团的筛选和分子对接研究表明,苯并咪唑-1,2,3-三唑杂合体是一种针对肺癌的新型 EGFR 抑制剂。
J Biomol Struct Dyn. 2024 Nov;42(18):9416-9438. doi: 10.1080/07391102.2023.2252496. Epub 2023 Aug 30.
4
Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.吲哚三唑缀合物的合成及初步临床评价,作为有效的微管靶向剂,针对 MCF-7 乳腺癌细胞系。
Anticancer Agents Med Chem. 2021;21(8):1047-1055. doi: 10.2174/1871520620666200925102940.
5
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.通过基于配体的药效团建模和分子对接研究,在计算机上鉴定小分子苯并呋喃-1,2,3-三唑杂化物作为肺癌中靶向表皮生长因子受体(EGFR)的潜在抑制剂。
In Silico Pharmacol. 2023 Aug 9;11(1):20. doi: 10.1007/s40203-023-00157-1. eCollection 2023.
6
Unveiling the anticancer mechanism of 1,2,3-triazole-incorporated thiazole-pyrimidine-isoxazoles: insights from docking and molecular dynamics simulations.揭示含1,2,3-三唑的噻唑-嘧啶-异恶唑的抗癌机制:来自对接和分子动力学模拟的见解
J Biomol Struct Dyn. 2024;42(24):13803-13815. doi: 10.1080/07391102.2023.2278749. Epub 2023 Dec 1.
7
In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer.计算机模拟鉴定和探索小分子香豆素-1,2,3-三唑杂化物作为靶向肺癌的潜在表皮生长因子受体(EGFR)抑制剂
Mol Divers. 2024 Dec;28(6):4301-4324. doi: 10.1007/s11030-024-10817-9. Epub 2024 Mar 12.
8
Design, synthesis, and antiproliferative activity of new 1,2,3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAF inhibitors.新型1,2,3-三唑/喹唑啉-4-酮杂合物作为双靶点EGFR/BRAF抑制剂的设计、合成及抗增殖活性
RSC Adv. 2024 Dec 5;14(52):38403-38415. doi: 10.1039/d4ra06694d. eCollection 2024 Dec 3.
9
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF kinases.设计并合成新型喹啉/查尔酮/1,2,4-三唑杂合体作为针对 EGFR 和 BRAF 激酶的有效增殖抑制剂。
Bioorg Chem. 2021 Jan;106:104510. doi: 10.1016/j.bioorg.2020.104510. Epub 2020 Nov 24.
10
A computational journey in anticancer drug discovery: Exploring AKT1 inhibition by novel oxadiazoles using molecular docking, ADMET, density functional theory and molecular dynamic simulation.抗癌药物发现中的计算之旅:利用分子对接、ADMET、密度泛函理论和分子动力学模拟探索新型恶二唑对AKT1的抑制作用
Comput Biol Chem. 2025 Aug;117:108425. doi: 10.1016/j.compbiolchem.2025.108425. Epub 2025 Mar 16.

本文引用的文献

1
Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020.2020年下咽癌的全球流行病学及社会经济相关因素及其至2040年的预测:来自全球癌症观察站(GLOBOCAN)2020的数据
Front Oncol. 2024 Sep 2;14:1398063. doi: 10.3389/fonc.2024.1398063. eCollection 2024.
2
Structural modification strategies of triazoles in anticancer drug development.三唑类化合物在抗癌药物研发中的结构修饰策略。
Eur J Med Chem. 2024 Sep 5;275:116578. doi: 10.1016/j.ejmech.2024.116578. Epub 2024 Jun 13.
3
Unraveling NEAT1's complex role in lung cancer biology: a comprehensive review.
解析NEAT1在肺癌生物学中的复杂作用:一篇综述
EXCLI J. 2024 Jan 3;23:34-52. doi: 10.17179/excli2023-6553. eCollection 2024.
4
Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review.含1,2,3-三唑的具有体内抗癌治疗潜力的杂化物的最新进展:一篇综述。
Eur J Med Chem. 2023 May 5;251:115254. doi: 10.1016/j.ejmech.2023.115254. Epub 2023 Mar 6.
5
Copper(I)-Catalyzed Alkyne-Azide Cycloaddition (CuAAC) "Click" Reaction: A Powerful Tool for Functionalizing Polyhydroxylated Platforms.铜(I)催化的炔烃-叠氮化物环加成(CuAAC)“点击”反应:一种用于多羟基平台功能化的强大工具。
ACS Omega. 2023 Jan 18;8(4):3650-3666. doi: 10.1021/acsomega.2c06269. eCollection 2023 Jan 31.
6
Therapeutic application of carvacrol: A comprehensive review.香芹酚的治疗应用:综述
Food Sci Nutr. 2022 Aug 3;10(11):3544-3561. doi: 10.1002/fsn3.2994. eCollection 2022 Nov.
7
Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.血液恶性肿瘤靶向治疗药物与唑类抗真菌药物的药物相互作用管理。
Lancet Haematol. 2022 Jan;9(1):e58-e72. doi: 10.1016/S2352-3026(21)00232-5. Epub 2021 Dec 8.
8
Anti-inflammatory and antioxidant activity of carvacrol in the respiratory system: A systematic review and meta-analysis.香芹酚在呼吸系统中的抗炎和抗氧化活性:系统评价和荟萃分析。
Phytother Res. 2020 Sep;34(9):2214-2229. doi: 10.1002/ptr.6688. Epub 2020 Apr 6.
9
Simultaneous determination of carvacrol and thymol in bee pollen by using a simple and efficient solvent extraction method and gas chromatography-mass spectrometry.采用简单高效的溶剂萃取法和气相色谱-质谱法同时测定蜂花粉中的香芹酚和百里香酚。
J Pharm Biomed Anal. 2020 Mar 20;181:113124. doi: 10.1016/j.jpba.2020.113124. Epub 2020 Jan 23.
10
Transdermal delivery enhancement of carvacrol from Origanum vulgare L. essential oil by microemulsion.微乳增强牛至精油香芹酚的透皮传递。
Int J Pharm. 2020 Apr 15;579:119052. doi: 10.1016/j.ijpharm.2020.119052. Epub 2020 Jan 23.